Detailed Information
Cited 35 time in 
Cited 35 time in 
Cited 35 time in
Metadata Downloads
Polymeric oncolytic adenovirus for cancer gene therapy
- Issue Date
- Dec-2015
- Publisher
- ELSEVIER SCIENCE BV
- Keywords
- Oncolytic adenovirus; Clinical trials; Cancer gene therapy; Oncolytic Ad/polymer hybrid vector; Active targeting; Tumor microenvironment targeting; Systemic administration
- Citation
- JOURNAL OF CONTROLLED RELEASE, v.219, pp.181 - 191
- Indexed
- SCIE
SCOPUS
- Journal Title
- JOURNAL OF CONTROLLED RELEASE
- Volume
- 219
- Start Page
- 181
- End Page
- 191
- ISSN
- 0168-3659
- Abstract
- Oncolytic adenovirus (Ad) vectors present a promising modality to treat cancer. Many clinical trials have been done with either naked oncolytic Ad or combination with chemotherapies. However, the systemic injection of oncolytic Ad in clinical applications is restricted due to significant liver toxicity and immunogenicity. To overcome these issues, Ad has been engineered physically or chemically with numerous polymers for shielding the Ad surface, accomplishing extended blood circulation time and reduced immunogenicity as well as hepatotoxicity. In this review, we describe and classify the characteristics of polymer modified oncolytic Ad following each strategy for cancer treatment. Furthermore, this review concludes with the highlights of various polymer-coated Ads and their prospects, and directions for future research. (C) 2015 Elsevier B.V. All rights reserved.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - 서울 공과대학 > 서울 생명공학과 > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Related Researcher
- Yun, Chae Ok
- COLLEGE OF ENGINEERING (DEPARTMENT OF BIOENGINEERING)